Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: Frequency, associated tumor characteristics, and impact on prognosis

Cancer

Volumn 83, Issue 5, 1998, Pages 858-866

  Natsugoe, Shoji ^a   Mueller, James ^a   Stein, Hubert J ^a   Feith, Marcus ^a   Höfler, Heinz ^b   Siewert, J Rüdiger ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Esophagus; Immunohistochemistry; Micrometastases; Squamous cell carcinoma

Indexed keywords

CYTOKERATIN; MONOCLONAL ANTIBODY; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 0032169815     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980901)83:5<858::AID-CNCR9>3.0.CO;2-E     Document Type: Article

References (39)

1. Muller J, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77:845-7.
2. Siewert JR, Roder JD. Lymphadenectomy in esophageal cancer surgery. Dis Esoph 1992;2:91-7.
3. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-72.
4. Baba M, Aikou T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H, et al. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994;219:310-6.
5. Natsugoe S, Shimazu H, Baba M, Yoshinaka H, Shimada M, Haraguchi Y, et al. Recurrence to thoracic esophageal cancer after lymph node dissection in three areas - with special reference to the relationship between recurrence and the number of metastatic lymph nodes. Jpn J Gastroenterol Surg 1991;24:2888-93.
6. Galea MH, Athanassiou E, Bell J, Dilks B, Robertson J, Elston CW, et al. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11. J Pathol 1991;165: 221-7.
7. Nasser IA, Lee A, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 1993;24: 950-7.
8. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: correlation with long-term survival. Cancer 1994;73:563-9.
9. Jeffers MD, O'Dowd GM, Mulchahy H, Stagg M, O'Donoghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172: 183-7.
10. Chen ZL, Perez S, Holmes EC, Wang HJ, Coulson WF, Wen D, et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 1993;85:493-8.
11. Passlick BB, Izbicki JR, Kubuschok B, Nathrath W, Thetter O, Pichlmeier U, et al. Immunohistochemical assessment of individual tumor cells in lymph nodes with non-small-cell lung cancer. J Clin Oncol 1994;12:1827-32.
12. Siewert JR, Kestlmeier R, Busch R, Böttcher K, Roder JD, Mueller J, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996;83:1144-7.
13. Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of lymph node micrometaastases from gastric carcinomas. Cancer 1997;79:1069-76.
14. Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin D, et al. Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 1988;27:483-7.
15. Kestlmeier R, Busch R, Fellbaum C, Mueller J, Böttcher K, Siewert J, et al. Frequency and prognostic significance of microcarcinosis and epithelioid-cell reactions in the regional lymph nodes of gastric carcinoma. In: Nishi M, Sugano H, Takahashi T, editors. First international gastric cancer congress - Book of abstracts. Kyoto: 1995;1777.
16. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-5.
17. Shiozaki H, Oka H, Inoue M, Tamura S, Monden M. E-cadherin mediated adhesion system in cancer cells. Cancer 1996;77:1605-13.
18. Jiang WG. E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg 1996;83:437-46.
19. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinoma of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991;51:6328-37.
20. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993;53:1690-5.
21. Becker KF, Atkinson MJ, Becker I, Nekarda H, Siewert JR, Höfler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;54:3845-52.
22. Kinsella AR, Green B, Lepts GC, Bowie G, Taylor BA. The role of the cell-cell adhesion molecule E-cadherin in large bowel tumor cell invasion and metastasis. Br J Cancer 1993;67: 904-9.
23. Yonemura Y, Nojima N, Kaji M, Fujimura T, Itoh H, Ninomiya I, et al. E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer 1995;76: 941-53.
24. Tamura S, Shiozaki H, Miyata M, Kadowaki T, Inoue M, Matsui S, et al. Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the esophagus. Br J Surg 1996;83:1608-14.
25. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the esophagus. Br J Surg 1994;81:410-3.
26. Hermanek P, Sobin LH, editors. TNM classification of malignant tumors. 4th ed. Berlin: Springer, International Union Against Cancer (UICC), 1987.
27. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. Tokyo, Kanehara, 1981:14-16.
28. Woodcock MJ, Eichner R, Nelson WG, Sun TT. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 1982;95:580-8.
29. Listrom MB, Dalton LW. Comparison of keratin monoclonal antibodies MAK-6, AE1:AE3, and CAM-5.2. Am J Clin Pathol 1987;88:297-301.
30. Doglioni C, Dell'Orto P, Zanetti G, Iuzzolino P, Coggi G, Viale G. Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunocytochemical study. Virchows Arch (A) 1990;416: 479-90.
31. Momburg F, Moldenhauer G, Hämmerling GJ, Möller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific glycoprotein in normal and malignant tissues. Cancer Res 1987;47: 2883-91.
32. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990;43: 213-9.
33. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-29.
34. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
35. Shiozaki H, Tahara H, Oka H, Miyata M, Kobayashi K, Tamura S, et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991; 139:17-23.
36. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-701.
37. Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically detected tumor cells in lymph nodes of patients with completely resected esophageal cancer. NEJM 1997;337: 1188-94.
38. Miyata M, Shiozaki H, Iihara K, Shimaya K, Oka H, Kadowaki T. Relationship between E-cadherin expression and lymph node metastasis in human esophageal cancer. Int J Oncol 1994;4:61-5.
39. Krishnadath KK, Tilanus HW, Van Balankenstein M, Hop WCJ, Kremers ED, Dinjens WNM, et al. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 1997;182:331-8.